Who owns XILIO THERAPEUTICS INC?
- Ticker: XLO
- CUSIP Number: 98422t100
Tip: Access positions for across all investors
Analyze quarterly positions in Xilio Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Xilio Therapeutics stock
Who bought or sold XILIO THERAPEUTICS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Atlas Venture Life Science Advisors | 2.8M | $1.5M | 0% | Dec 2023 |
|
| Octagon Capital Advisors | 1.8M | $982k | -23% | Dec 2023 |
|
| RiverVest Venture Management | 1.4M | $793k | 0% | Dec 2023 |
|
| Vanguard Group | 903k | $496k | 1% | Dec 2023 |
|
| Artal Group | 450k | $248k | 0% | Dec 2023 |
|
| Laurion Capital Management | 117k | $64k | -16% | Dec 2023 |
|
| Arrowpoint Asset Management | 83k | $46k | 100% | Dec 2023 |
|
| Citadel Advisors | 51k | $28k | 100% | Dec 2023 |
|
| Millennium Management | 30k | $17k | 100% | Dec 2023 |
|
| Charles Schwab Investment Management | 12k | $6.6k | 0% | Dec 2023 |
|
| Virtu Financial | 11k | $6.0k | 100% | Dec 2023 |
|
| Dunhill Financial | 10k | $5.7k | 100% | Dec 2023 |
|
| Jpmorgan Chase & Co | 2.9k | $1.6k | 5% | Dec 2023 |
|
| Key FInancial | 830.00 | $456.002000 | 0% | Dec 2023 |
|
| Royal Bank of Canada | 468.00 | $0 | 34% | Dec 2023 |
|
| UBS Group | 201.00 | $110.992200 | 0% | Dec 2023 |
|
| Wells Fargo & Company | 106.00 | $58.003200 | 6% | Dec 2023 |
|
| Cullen Frost Bankers | 100.00 | $55.000000 | 0% | Dec 2023 |
|
| Bank of America Corporation | 11.00 | $6.000500 | -100% | Dec 2023 |
|
Who sold out of Xilio Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Harvard Management Company | Sep 2023 | 416k | $878k |
| Soleus Capital Management | Sep 2023 | 227k | $479k |
| Dimensional Fund Advisors | Sep 2023 | 26k | $56k |